Sensorium Therapeutics Pipeline
| Drug | Indication | Phase |
|---|
| SENS-01 | Social Anxiety Disorder (with potential in GAD, OCD, PTSD) | Phase 1 |
| SENS-03 | Drug-resistant epilepsy (with co-occurring anxiety) | Preclinical |
| SENS-08 | Alzheimer's-related cognitive impairment | Preclinical |